Format

Send to

Choose Destination
Sleep. 2018 May 1;41(5). doi: 10.1093/sleep/zsy044.

Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS).

Author information

1
Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA.
2
Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, CA.
3
VA Greater Los Angeles Healthcare System, Geriatric Research, Education and Clinical Center, Los Angeles, CA.
4
School of Medicine, Johns Hopkins University, Baltimore, MD.
5
Department of Medicine, University of Utah, Salt Lake City, UT.
6
Department of Medicine, University of Michigan, Ann Arbor, MI.
7
Department of Medicine, Columbia University, New York City, NY.
8
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
9
University of Illinois at Chicago, Chicago, IL.
10
Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
11
Department of Medicine, University of California, San Francisco, CA.
12
School of Medicine, Wayne State University, Detroit, MI.

Abstract

Study Objectives:

Sleep quality is poor among patients with chronic obstructive pulmonary disease (COPD), and studies show that sleep disturbance is associated with low overall quality of life in this population. We evaluated the impact of patient-reported sleep quality and sleep apnea risk on disease-specific and overall quality of life within patients with COPD enrolled in the SPIROMICS study, after accounting for demographics and COPD disease severity.

Methods:

Baseline data from 1341 participants [892 mild/moderate COPD (FEV1 ≥ 50% predicted); 449 severe COPD (FEV1 < 50%)] were used to perform three nested (blocks) regression models to predict quality of life (Short Form-12 mental and physical components and St. George's Respiratory Questionnaire). Dependent measures used for the nested regressions included the following: Block1: demographics and smoking history; Block 2: disease severity (forced expiratory volume 1 s; 6 min walk test); Block 3: risk for obstructive sleep apnea (OSA; Berlin questionnaire); and Block 4: sleep quality (Pittsburgh Sleep Quality Index [PSQI]).

Results:

Over half of participants with COPD reported poor sleep quality (Mean PSQI 6.4 ± 3.9; 50% with high risk score on the Berlin questionnaire). In all three nested regression models, sleep quality (Block 4) was a significant predictor of poor quality of life, over and above variables included in blocks 1-3.

Conclusions:

Poor sleep quality represents a potentially modifiable risk factor for poor quality of life in patients with COPD, over and above demographics and smoking history, disease severity, and risk for OSA. Improving sleep quality may be an important target for clinical interventions.

Clinical Trial:

SPIROMICS.

Clinical Trial URL:

http://www2.cscc.unc.edu/spiromics/.

Clinical Trial Registration:

ClinicalTrials.gov NCT01969344.

PMID:
29534240
PMCID:
PMC5946919
DOI:
10.1093/sleep/zsy044
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center